Anti-Tumor Effect of Orally Administered Spinach Glycolipid Fraction on Implanted Cancer Cells, Colon-26, in Mice - Maeda, Naoki; Kokai, Yasuo; Ohtani, Seiji; Sahara, Hiroeki; Kumamoto-Yonezawa, Yuko; Kuriyama, Isoko; Hada, Takahiko; Sato, Noriyuki; Yoshida, Hiromi; Mizushina, Yoshiyuki (Lipids, 2008)
Keywords: adenocarcinoma; administration & dosage; Administration, Oral; animal disease models; Animals; anticarcinogenic activity; Antineoplastic Agents; Antineoplastic Agents - standards; Anti‐angiogenesis activity; Anti‐cancer cell growth activity; Anti‐tumor activity; Biomedical and Life Sciences; biosynthesis; blood supply; Body weight; Cell Line, Tumor; cell proliferation; Cell Proliferation - drug effects; chemistry; Colonic Neoplasms; Colonic Neoplasms - blood supply; Colonic Neoplasms - drug therapy; Colonic Neoplasms - pathology; colorectal neoplasms; drug effects; drug therapy; Female; Glycolipid; glycolipids; Glycolipids - administration & dosage; Glycolipids - biosynthesis; Glycolipids - chemistry; Glycolipids - therapeutic use; human health; Humans; Life Sciences; Lipidology; Medical Biochemistry; Medicinal Chemistry; metabolism; Mice; Mice, Inbred BALB C; Microbial Genetics and Genomics; Neoplasm Transplantation; Neurochemistry; Nutrition; oral administration; Original Article; pathology; Spinach; Spinacia oleracea; Spinacia oleracea - metabolism; therapeutic use; Tumors; Spinach; Anti-angiogenesis activity; Anti-tumor activity; Glycolipid; Anti-cancer cell growth activity